Median Technologies S.A. (4ZG)

Overview

Median Technologies SA is a pioneering firm in the field of medical image analysis, with its activities spanning across various countries including France, the United States, Canada, the United Kingdom, China, and internationally. Founded in 2002 and headquartered in Valbonne, France, the company specializes in developing and marketing advanced software products and platforms designed to enhance the diagnosis and treatment of medical conditions. Through its innovative solutions, Median Technologies aims to leverage the power of artificial intelligence to improve the efficiency and accuracy of medical diagnostics in oncology and other areas related to fibrotic diseases.

Products and Services

• iBiops

  An end-to-end artificial intelligence-powered software, certified as a medical device, iBiops stands out for its capability to facilitate early diagnosis of cancers and fibrotic diseases. By integrating groundbreaking AI technology, iBiops enhances the precision and speed of diagnosing these life-threatening conditions.

• iSee

  iSee is tailored for image analysis services within clinical trials, providing robust solutions for data management and analysis. This platform embodies Median Technologies’ commitment to advancing the field of medical research by offering sophisticated tools that streamline the process of analyzing clinical trial images, thereby enabling more efficient study outcomes.

• iCRO

  Focused on the delivery of imaging services for clinical trials specifically in the realm of oncology, iCRO utilizes sophisticated software to aid in the study of cancer treatments. This service underscores the company's expertise in integrating software solutions with clinical research, aiming to improve the development of oncological therapeutics through enhanced imaging analysis capabilities.